FDA Approves Benralizumab for EGPA Vasculitis Indication ...Middle East

News by : (Medscape) -
In a clinical trial, nearly 60% of participants achieved remission and 41% fully tapered off oral corticosteroids. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Benralizumab for EGPA Vasculitis Indication )

Also on site :

Most Viewed News
جديد الاخبار